175 related articles for article (PubMed ID: 37548686)
1. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials.
Cheng L; Yan J; Han S; Chen Q; Chen M; Jiang H; Lu J
Crit Care; 2019 May; 23(1):168. PubMed ID: 31088524
[TBL] [Abstract][Full Text] [Related]
3. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
4. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
[TBL] [Abstract][Full Text] [Related]
5. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
6. Vasopressor Therapy in the Intensive Care Unit.
Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
[TBL] [Abstract][Full Text] [Related]
7. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
8. Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials.
Chen C; Pang L; Wang Y; Wen T; Yu W; Yue X; Rong Y; Liao W
Ann Transl Med; 2019 Oct; 7(20):535. PubMed ID: 31807517
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive drugs in the intensive care unit.
Holmes CL
Curr Opin Crit Care; 2005 Oct; 11(5):413-7. PubMed ID: 16175026
[TBL] [Abstract][Full Text] [Related]
11. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Oba Y; Lone NA
J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
[TBL] [Abstract][Full Text] [Related]
12. Vasopressors for shock.
Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
[TBL] [Abstract][Full Text] [Related]
16. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
[TBL] [Abstract][Full Text] [Related]
17. Effect of Continuous Epinephrine Infusion on Survival in Critically Ill Patients: A Meta-Analysis of Randomized Trials.
Belletti A; Nagy A; Sartorelli M; Mucchetti M; Putzu A; Sartini C; Morselli F; De Domenico P; Zangrillo A; Landoni G; Lembo R
Crit Care Med; 2020 Mar; 48(3):398-405. PubMed ID: 31789701
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis.
Huang L; Zhang S; Chang W; Xia F; Liu S; Yang Y; Qiu H
BMC Anesthesiol; 2020 Mar; 20(1):58. PubMed ID: 32138657
[TBL] [Abstract][Full Text] [Related]
19. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]